nibrozetone (RRx-001)

News alerts, weekly reports and conference planners

Company:

EpicentRx, SciClone

Drug class:

CD47 inhibitor, MYC inhibitor, NLRP3 inhibitor, NRF2 activator, SIRPA antagonist

PD-L1 expression	Small Cell Lung Cancer	PD-L1 expression	Small Cell Lung Cancer	RRx-001 Sensitive: C3 – Early Trials RRx-001 Sensitive : C3	RRx-001 Sensitive: C3 – Early Trials RRx-001 Sensitive : C3
MRC1 expression	Small Cell Lung Cancer	MRC1 expression	Small Cell Lung Cancer	RRx-001 Sensitive: C3 – Early Trials RRx-001 Sensitive : C3	RRx-001 Sensitive: C3 – Early Trials RRx-001 Sensitive : C3

Associations
(2)